ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

Clinical trials for ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION explained in plain language.

Never miss a new study

Get alerted when new ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION trials appear

Sign up with your email to follow new studies for ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Vitamin b tested to speed recovery after Life-Saving transplants

Disease control Recruiting now

This small, early-stage study is testing whether a common vitamin B supplement called nicotinamide riboside (TRU NIAGEN) is safe and tolerable for patients receiving a bone marrow transplant from a donor. The goal is to see if this supplement can help the donor cells settle in an…

Matched conditions: ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

Phase: EARLY_PHASE1 • Sponsor: Case Comprehensive Cancer Center • Aim: Disease control

Last updated Mar 13, 2026 15:06 UTC

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

Get alerted when new ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION trials appear

Vitamin b tested to speed recovery after Life-Saving transplants